No effect of enalapril on progression in autosomal dominant polycystic kidney disease | Zendy

Marjan A. van Dijk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

No effect of enalapril on progression in autosomal dominant polycystic kidney disease

Author(s) -

Marjan A. van Dijk

Publication year - 2003

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfg417

Subject(s) - enalapril , medicine , microalbuminuria , atenolol , renal function , urology , autosomal dominant polycystic kidney disease , blood pressure , ace inhibitor , endocrinology , proteinuria , polycystic kidney disease , placebo , albuminuria , angiotensin converting enzyme , kidney , pathology , alternative medicine

Angiotensin-converting enzyme (ACE) inhibitors are capable of reducing proteinuria and microalbuminuria with preservation of renal function in diabetic and non-diabetic renal disease. We designed a study investigating the effect of enalapril on the protection of renal function in autosomal dominant polycystic kidney disease (ADPKD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research